Alzheimer’s treatment
HealthETH Zurich scientists developed a new drug to slow Alzheimer’s development
A new ETH Zurich compound slowed Alzheimer’s-like brain damage in mice by blocking harmful GRK2 protein clumps.
Joseph Shavit